Results 91 to 100 of about 12,238 (214)

The protective effects of cysteamine, putrescine, and the combination of cysteamine and putrescine on fibrosarcoma induced in mice with 3-methylcholanthrene

open access: yes, 2016
In this study, the protective effects of cysteamine, putrescine, and the combination of cysteamine and putrescine were investigated in mice with fibrosarcoma induced with 3-methylcholanthrene (3-MC).
Erdağ D.   +11 more
core   +1 more source

Effect of cysteamine on serum enzymes and creatinine levels.

open access: yes, 2012
Tumor bearing mice were treated with increasing doses of cysteamine and serum was collected from tail veins twice, i.e., pre-cysteamine treatment (day 4) and post- treatment (day 18).
Benjamin Rubin (169516)   +6 more
core   +1 more source

Comparison between the efficacy of cysteamine cream and combined hydroquinone cream in the treatment of melasma using skin analytical systems: An open-label quasi-randomized controlled trial in Asia patients

open access: yesDermatologica Sinica
Background: The mainstay of treatment for melasma is topical hydroquinone or preparations containing hydroquinone. In recent years, cysteamine cream has gained popularity in the treatment of hyperpigmentation disorders.
Andy Deng-Chi Chuang   +6 more
doaj   +1 more source

Efficacy and safety of cysteamine in the treatment of melasma: a systematic review and meta-analysis of randomized controlled trials

open access: yesJournal of the Egyptian Women’s Dermatologic Society
Melasma is a persistent and recurrent pigmentation disorder that significantly impacts patients’ quality of life and presents challenges in management with conventional treatments.
Monica Trifitriana   +2 more
doaj   +1 more source

Prolonged release pharmaceutical composition comprising cysteamine or salt thereof

open access: yes, 2021
A prolonged release multiple unit dosage form, preferably pellets, of cysteamine, cystamine or a pharmaceutically acceptable salt thereof, preferably cysteamine bitartrate, with a non gastro-resistant coating is described. The dosage form is particularly
A. Maroni   +3 more
core   +1 more source

Improving the prognosis of nephropathic cystinosis

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2014
Martine TP Besouw,1,2 Elena N Levtchenko1,21Department of Pediatric Nephrology, University Hospitals Leuven, Belgium; 2Laboratory of Pediatrics, Catholic University Leuven, Leuven, BelgiumAbstract: Cystinosis is an autosomal recessive inherited lysosomal
Besouw MTP, Levtchenko EN
doaj  

Radioprotective Efficacy of Cysteamine [PDF]

open access: yesActa Radiologica: Therapy, Physics, Biology, 1964
A, BOSE, S, BOSE, P, DE
openaire   +2 more sources

Cysteamine 에 의한 세포사멸, ER 스트레스, 그리고 염증반응의 조절 기전

open access: yes, 2021
학위논문 (박사) -- 서울대학교 대학원 : 의과대학 의과학과, 2021. 2. 김인규.시스티아민은 Coenzyme A 분해과정에서 생성되는 thiolamine으로 세포내에서 PKC1, Transglutaminase 2 (TG2), caspase 3의 효소활성을 억제한다.
이진행
core  

Cysteamine selectively enhances neuropeptide Y2 receptor binding activity

open access: yes, 1992
Affinity labeling of [125I]NPY to the bovine hippocampal NPY receptor has revealed a 50 kDa specific binding protein, the Y2 receptor. Cysteamine (10 μM – 10 mM) specifically enhanced NPY specific labeling of the Y2 receptor without affecting ...
Li, Wei, Hexum, Terry D
core   +1 more source

Mitigative role of cysteamine against unilateral renal reperfusion injury in Wistar rats

open access: yesFrontiers in Pharmacology
BackgroundIschemia-reperfusion injury (IRI) is unavoidable during kidney transplant and it is responsible for delayed or non-function after kidney transplantation. Cysteamine is the standard drug in the management of nephropathic cystinosis and its extra-
Babatunde Adebola Alabi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy